85P: Performance of EBUS-TBNA in NSCLC mediastinal staging stratified according to ACCP radiographic groups on CT

Edwards, Timothy L.; Al-Najjar, Haider; Martin, Julie; Booton, Richard; Evison, Matthew

doi:10.1016/s1556-0864(16)30198-8

Cited by 2 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reporting of diagnostic sensitivity according to ACCP radiographic group (A–D) may be less resource‐intensive as this feature is identifiable at the time of EBUS, and therefore can be recorded in the procedure report. Approximate prevalence of disease is described according to radiographic group, and may aid reporting of diagnostic performance of EBUS‐TBNA 122 Non‐small cell lung cancer central parenchymal lesions …”

Section: Resultsmentioning

confidence: 99%

“…In contrast, consistent procedural reporting in performance of endoscopic ultrasound has demonstrated in quality indicator adherence by ensuring comprehensive documentation while limiting error. 122 Significant variation in reporting of EUS is well recognized, 28 though no such evidence exists for EBUS bronchoscopy.…”

Section: Discussionmentioning

confidence: 99%

“…Inconsistent procedural reporting results in significant challenges to internal audit and external benchmarking, thus limiting opportunities for quality improvement. In contrast, consistent procedural reporting in performance of endoscopic ultrasound has demonstrated in quality indicator adherence by ensuring comprehensive documentation while limiting error 122 . Significant variation in reporting of EUS is well recognized, 28 though no such evidence exists for EBUS bronchoscopy.…”

Section: Discussionmentioning

confidence: 99%

“…Approximate prevalence of disease is described according to radiographic group, and may aid reporting of diagnostic performance of EBUS-TBNA. 122 b. Non-small cell lung cancer central parenchymal lesions Performance Target: Sensitivity ≥90%. Kuijvenhoven et al performed a systemic review of EBUS-TBNA diagnosis of central lung tumours and found a pooled sensitivity of 91% (95% CI 88-94%) from 14 studies.…”

Section: Diagnostic Performance Of Ebus-tbna According To Indication/...mentioning

confidence: 99%

See 3 more Smart Citations

Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology Expert Panel consensus statement

et al. 2023

View full text Add to dashboard Cite

Background Since their introduction, both linear and radial endobronchial ultrasound (EBUS) have become an integral component of the practice of Pulmonology and Thoracic Oncology. The quality of health care can be measured by comparing the performance of an individual or a health service with an ideal threshold or benchmark. The taskforce sought to evaluate quality indicators in EBUS bronchoscopy based on clinical relevance/importance and on the basis that observed significant variation in outcomes indicates potential for improvement in health care outcomes. Methods A comprehensive literature review informed the composition of a comprehensive list of candidate quality indicators in EBUS. A multiple‐round modified Delphi consensus process was subsequently performed with the aim of reaching consensus over a final list of quality indicators and performance targets for these indicators. Standard reporting items were developed, with a strong preference for items where evidence demonstrates a relationship with quality indicator outcomes. Results Twelve quality Indicators are proposed, with performance targets supported by evidence from the literature. Standardized reporting items for both radial and linear EBUS are recommended, with evidence supporting their utility in assessing procedural outcomes presented. Conclusion This statement is intended to provide a framework for individual proceduralists to assess the quality of EBUS they provide their patients through the identification of clinically relevant, feasible quality measures. Emphasis is placed on outcome measures, with a preference for consistent terminology to allow communication and benchmarking between centres.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Diagnostic Performance Of Ebus-tbna According To Indication/...mentioning

confidence: 99%

See 2 more Smart Citations

Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology Expert Panel consensus statement

et al. 2023

View full text Add to dashboard Cite

show abstract

Endobronchial Ultrasound for Nodal Staging of Patients with Non–Small-Cell Lung Cancer with Radiologically Normal Mediastinum. A Meta-Analysis

El-Osta¹,

Jani

Mansour³

et al. 2018

Annals ATS

View full text Add to dashboard Cite

Among patients with non-small-cell lung cancer with a radiologically normal mediastinum, the prevalence of mediastinal disease is 12.8% and the sensitivity of endobronchial ultrasound-guided transbronchial needle aspiration is 49.5%. Despite the low sensitivity, the resulting negative predictive value of 93.0% for endobronchial ultrasound-guided transbronchial needle aspiration suggests that mediastinal metastasis is uncommon in such patients.

show abstract

85P: Performance of EBUS-TBNA in NSCLC mediastinal staging stratified according to ACCP radiographic groups on CT

Cited by 2 publications

References 0 publications

Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology Expert Panel consensus statement

Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology Expert Panel consensus statement

Endobronchial Ultrasound for Nodal Staging of Patients with Non–Small-Cell Lung Cancer with Radiologically Normal Mediastinum. A Meta-Analysis

Contact Info

Product

Resources

About